Persephone Biosciences
A first-of-its-kind combination of probiotics and prebiotics.
Persephone Biosciences makes a synbiotic supplement for infants that combines keystone probiotic strains with HMO prebiotics found in human breast milk. The product is designed to replenish beneficial Bifidobacterium gut bacteria that research shows are missing in nine out of ten U.S. babies. It is clinically validated, third-party tested, and developed by microbiome scientists and pediatricians.
The product pairs keystone probiotic strains with HMO prebiotics to replenish missing beneficial gut bacteria in infants during critical early development.
Parents of infants and newborns
Background.
- Status
- launched
- Business model
- unknown
- Company
- Persephone Biosciences
Founders
- Stephanie Culler, PhDsite
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.